{
  "docId": "019de075-e109-770f-8f32-3054686041b6",
  "docSlug": "9819f3512e565b918c6cfc8e3688cfb2",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Spyre Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 38,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/32",
  "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6",
  "deckJsonHref": "/decks/019de075-e109-770f-8f32-3054686041b6.json",
  "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.075,
        "w": 0.37,
        "x": 0.63,
        "y": 0.675
      },
      "kind": "callout",
      "text": "SPY130 Phase 2 study initiation expected in 2025",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d6275a3-a281-47ed-93f3-cfaaf379d2ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.764,
        "x": 0.208,
        "y": 0.306
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40ca1fe2-1b7e-41cd-b03e-ae5d70348bf5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.057,
        "w": 0.345,
        "x": 0.126,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "COMBINATION OF POTENTIALLY BEST-IN-CLASS MONOTHERAPY BUILDING BLOCKS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22951170-4f11-478c-92d6-efcf9b310ca0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.057,
        "w": 0.273,
        "x": 0.657,
        "y": 0.468
      },
      "kind": "paragraph",
      "text": "DEVELOPING PATIENT SELECTION APPROACHES TO IDENTIFY RESPONDERS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae99978b-f156-47e3-a291-8bb12ea7cb7f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.057,
        "w": 0.204,
        "x": 0.395,
        "y": 0.468
      },
      "kind": "paragraph",
      "text": "TARGETING UNIFIED Q8-12W DOSING FOR OPTIMIZED PATIENT CONVENIENCE",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8ff28ea-15c0-45f9-af18-76dce82158d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.091,
        "w": 0.518,
        "x": 0.026,
        "y": 0.044
      },
      "kind": "title",
      "text": "Combination programs summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2419b94e-70b0-4bd0-b259-689534ffea11",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}